People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Immunophotonics, Inc. | — | Pharmaceuticals | Seed | $8.1M | $8.6M | 2023 |
Luciano Alleruzzo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Luciano Alleruzzo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David R. Smoller | 1 | 2 |
| Charlie R. Bolten | 1 | 2 |
| Bobby W. Sandage | 1 | 2 |
| Shelly L. Bishop | 1 | 1 |
| Peter A. Jenkins | 1 | 1 |
| Charlie E. Bolten | 1 | 1 |
| Bobby E. Sandage | 1 | 1 |
| Lu Alleruzzo | 1 | 1 |
| Miguel R. Zubizarreta | 1 | 1 |
| Tomas Hode | 1 | 1 |
| Jonathan R. Knowles | 1 | 1 |
| Wei R. Chen | 1 | 1 |
| Robert E. Nordquist | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.